MENTOR, Ohio -- STERIS Corporation today announced that Timothy L. Chapman has joined the company as senior vice president of business strategy, filling a newly created position.
Chapman, 43, will become a member of STERIS Corporation's senior management team, reporting to Les C. Vinney, president and chief executive officer. He has responsibility for leading STERIS's strategic planning, business development and supply chain management activities. Chapman will also have responsibility for leading the company's multi-year performance transformation program designed to improve business and management processes and establish a common culture at STERIS.
"Having served STERIS in a consulting role for several years, Tim joins us with a deep understanding of our operations," said Vinney. "In addition, his wealth of operational and healthcare industry experience, managing issues for an array of institutions such as hospital, medical supply and insurance clients, makes him a valued addition as he brings a unique perspective to our organization."
Chapman joins STERIS Corporation from McKinsey & Company's Cleveland office, where he was most recently a director responsible for managing a number of client service efforts. During his more than 20 years with McKinsey, he founded and led the purchasing and supply management practice, and went on to lead the operations practice, which encompasses manufacturing, product development, supply chain, service operations and purchasing. For 15 years, Chapman has served as a leader in McKinsey's healthcare practice, working closely with numerous healthcare institutions on a broad range of organizational, strategic and operational issues.
Chapman earned a bachelor's degree in economics from DartmouthCollege and a master's degree in business administration with distinction from the AmosTuckSchool at Dartmouth. He is a board member of the Make-A-Wish Foundation of Greater Ohio and Kentucky, and previously served that organization as a national board member.
Source: STERIS Corporation
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.